Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for BIOHARVEST SCIENCES INC. (CNVCF:NASDAQ), powered by AI.
BIOHARVEST SCIENCES INC. is currently trading at $3.09. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for BIOHARVEST SCIENCES INC. on Alpha Lenz.
BIOHARVEST SCIENCES INC.'s P/E ratio is -3.3.
“BIOHARVEST SCIENCES INC. trades at a P/E of -3.3 (undervalued) with strong ROE of 120.9%. 3Y revenue CAGR of 217.5% highlights clear growth momentum.”
Ask for details →BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
“BIOHARVEST SCIENCES INC. trades at a P/E of -3.3 (undervalued) with strong ROE of 120.9%. 3Y revenue CAGR of 217.5% highlights clear growth momentum.”
Ask for details →BIOHARVEST SCIENCES INC. (ticker: CNVCF) is a company listed on NASDAQ in the Consumer Defensive sector (Packaged Foods). Market cap is $42M.
The current price is $3.09 with a P/E ratio of -3.33x and P/B of -2.82x.
ROE is 120.91% and operating margin is -78.65%. Annual revenue is $13M.